Did CDSCO Flag 205 Drug Samples as ‘Not of Standard Quality’ in November?
Click to start listening
Synopsis
In a significant move, the CDSCO has identified 205 drug samples as 'Not of Standard Quality' in November, highlighting ongoing efforts to maintain drug safety standards. This comprehensive report sheds light on the quality control measures being enforced and the implications for public health.
Key Takeaways
- 205 drug samples flagged as NSQ in November.
- 64 samples from Central Labs and 141 from State Labs.
- Regular monitoring helps maintain drug safety standards.
- Two samples identified as spurious from North Zone.
- Collaboration with state regulators is critical.
New Delhi, Dec 19 (NationPress) The Central Drugs Standard Control Organisation (CDSCO) announced on Friday that 205 drug samples assessed by both Central and state regulatory authorities have been classified as ‘Not of Standard Quality (NSQ)’ in its November drug alert.
Out of these, the Central Drugs Laboratories marked 64 drug samples as NSQ, while the State Drugs Testing Laboratories reported 141 samples falling into the same category.
In accordance with routine regulatory oversight, the CDSCO portal displays a monthly list of drugs identified as Not of Standard Quality and those deemed spurious.
“For November 2025, the Central Drugs Laboratories identified 64 drug samples as Not of Standard Quality, and the State Drugs Testing Laboratories reported 141 drug samples as NSQ,” the alert stated.
Designation of drug samples as NSQ is based on the failure of the samples to meet specified quality standards. This assessment pertains strictly to the tested batch, and does not imply concerns regarding other products available in the market, according to health officials.
Additionally, in November, “two drug samples from the North Zone in Ghaziabad were flagged as spurious, manufactured by unauthorized entities using the brand names of legitimate companies,” they noted. Investigations are ongoing, and actions will be undertaken in accordance with relevant Acts and Rules.
This initiative to pinpoint NSQ and spurious medicines is carried out in regular collaboration with state regulators to ensure the removal of these drugs from circulation.
In October, the CDSCO had reported 211 drug samples tested by Central and state regulatory authorities as NSQ.
While the Central Drugs Laboratories recognized 63 drug samples as NSQ, the State Drugs Testing Laboratories identified 148 drug samples as NSQ.
Point of View
It is crucial for the CDSCO to maintain rigorous quality checks on pharmaceuticals. The identification of NSQ and spurious drugs is vital in protecting public health. This proactive approach not only reassures consumers but also strengthens the overall integrity of the drug supply chain. Such vigilance from authorities is necessary to uphold safety standards in the pharmaceutical sector.
NationPress
22/12/2025
Frequently Asked Questions
What does NSQ stand for?
NSQ stands for 'Not of Standard Quality', indicating that the drug samples did not meet the required quality standards.
How many drug samples were flagged in November?
A total of 205 drug samples were flagged as 'Not of Standard Quality' by the CDSCO in their November report.
What actions are taken against spurious drugs?
The CDSCO collaborates with state regulators to identify and remove spurious drugs from the market, ensuring consumer safety.
